Sun Pharmaceutical Industries Limited vs Unihealth Hospitals Limited

A side-by-side comparison of Sun Pharmaceutical Industries Limited (SUNPHARMA) and Unihealth Hospitals Limited (UNIHEALTH) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Sun Pharmaceutical Industries Limited vs Unihealth Hospitals Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation31
  • Profitability04
  • Growth02
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

SUNPHARMA takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

36.79
P/E ratio
32.39
5.35
P/B ratio
8.29
0.86%
Dividend yield
0.00%
₹47.80
EPS
₹16.67

Profitability

UNIHEALTH takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

13.74%
Return on equity
18.77%
17.46%
Return on capital
28.71%
30.33%
EBITDA margin
40.76%
19.69%
Net margin
34.64%

Growth

UNIHEALTH takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.03%
Revenue CAGR (3Y)
44.22%
10.57%
Profit CAGR (3Y)
78.80%

Size & financial health

SUNPHARMA takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹4.22L Cr
Market cap
₹859 Cr
₹58,462 Cr
Revenue
₹132 Cr
₹11,509 Cr
Net profit
₹46 Cr
0.06
Debt / equity
0.24
Sun Pharmaceutical Industries Limited
  • + ["Company has delivered good profit growth of 38.3% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 33.4%", "Company is almost debt free."]
  • − ["Stock is trading at 5.05 times its book value"]
Unihealth Hospitals Limited
  • + ["Company has delivered good profit growth of 55.7% CAGR over last 5 years", "Company has a good return on equity (ROE) track record: 3 Years ROE 28.3%", "Company has delivered good sales growth of 38.4% CAGR over last 5 years"]
  • − ["Stock is trading at 6.24 times its book value", "Though the company is reporting repeated profits, it is not paying out dividend"]
Sun Pharmaceutical Industries Limited full analysis Unihealth Hospitals Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.